Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sino Medical Sciences TechnologySHSE:688108 -0.54%81 Cyclically Adjusted PS Ratio is 19.87 as of Aug. 22, 2026, which is 17% below its 10-year median of 23.95. GuruFocus rates SHSE:688108 with a GF Score™ of 81/100 and a GF Value™ of ¥21.00 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 523 Medical Devices & Instruments companies, Sino Medical Sciences Technology ranks worse than 96.75% on this metric.
The historical rank and industry rank for Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio or its related term are showing as below:
SHSE:688108'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 20.5 Med: 23.95 Max: 26.16
Current: 20.5
During the past 10 years, Sino Medical Sciences Technology's highest Cyclically Adjusted PS Ratio was 26.16. The lowest was 20.50. And the median was 23.95.
SHSE:688108's Cyclically Adjusted PS Ratio is ranked worse than 96.75% of 523
companies
in the Medical Devices & Instruments industry
Industry Median: 2.3
vs SHSE:688108: 20.50
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Sino Medical Sciences Technology's adjusted revenue per share data of for the fiscal year that ended in Dec25 was ¥1.222. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥0.93 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Sino Medical Sciences Technology (SHSE:688108) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Sino Medical Sciences Technology Cyclically Adjusted PS Ratio Related Terms
Sino Medical Sciences Technology Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Medical Sciences Technology Cyclically Adjusted PS Ratio Chart
SHSE:688108 vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison
For the Medical Devices subindustry, Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Medical Sciences Technology Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio falls into.
Sino Medical Sciences Technology Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 19.87 mean?
Sino Medical Sciences Technology (SHSE:688108) has a Cyclically Adjusted PS Ratio of 19.87 as of Aug. 22, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sino Medical Sciences Technology and its competitors. This is 17% below median its historical median of 23.95. Over the past decade, Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio has ranged from 20.50 to 26.16. According to the industry distribution chart, Sino Medical Sciences Technology ranks #506 out of 523 companies in the Medical Devices & Instruments industry, placing it in the top 96.7%.
Is Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio too high?
Sino Medical Sciences Technology's current Cyclically Adjusted PS Ratio of 19.87 is 17% below median its 10-year median of 23.95. Over the past 10 years, this metric has ranged from a low of 20.50 to a high of 26.16. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.30. Sino Medical Sciences Technology's value of 19.87 is 763.9% above this industry median. Based on the distribution chart, Sino Medical Sciences Technology ranks #506 out of 523 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sino Medical Sciences Technology has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sino Medical Sciences Technology's Cyclically Adjusted PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sino Medical Sciences Technology ranks #506 out of 523 companies for Cyclically Adjusted PS Ratio. This places Sino Medical Sciences Technology in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 2.30. Sino Medical Sciences Technology's value of 19.87 is 763.9% above this benchmark. Historically, Sino Medical Sciences Technology's own Cyclically Adjusted PS Ratio has ranged from 20.50 to 26.16 over the past decade. While the company's 10-year median is 23.95 vs. the industry median of 2.30, Sino Medical Sciences Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.30, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Medical Sciences Technology's current Cyclically Adjusted PS Ratio of 19.87 is 763.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sino Medical Sciences Technology and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Medical Sciences Technology's current Cyclically Adjusted PS Ratio is 19.87, which is 17% below median its own 10-year median of 23.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Medical Sciences Technology stock overvalued right now?
Based on GuruFocus' analysis, Sino Medical Sciences Technology (SHSE:688108) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.00, compared to a current price of ¥18.48 — trading 12% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 19.87, which is 17% below median its 10-year median of 23.95 and 763.9% above the Medical Devices & Instruments industry median of 2.30. Sino Medical Sciences Technology's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Sino Medical Sciences Technology (SHSE:688108), the current Cyclically Adjusted PS Ratio is 19.87 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Medical Sciences Technology (SHSE:688108) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Medical Sciences Technology stock appears to be undervalued.
The current stock price of ¥18.48 is trading 12% below its estimated GF Value™ of ¥21.00.
GuruFocus considers Sino Medical Sciences Technology to be Modestly Undervalued.
Key valuation signals for SHSE:688108:
Cyclically Adjusted PS Ratio: 19.87 (17% below median its 10-year median of 23.95)
GF Value™: ¥21.00 vs. price of ¥18.48 (12% below fair value)
Industry Position: 763.9% above the Medical Devices & Instruments median (#506 of 523)
No single metric tells the full story. See the SHSE:688108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Medical Sciences Technology Inc is a China based company engaged in the research, development, production and sales of high-end interventional medical devices.
81GF Score
Get the complete analysis for SHSE:688108
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688108 has been successfully added to your 
